Xeris Pharmaceuticals | Profitto Lordo Sulle Vendite



Gross Profit On Sales Cambiamento Data
Adcock Ingram Holdings ZAR 1.54B 73.26M 2024-12
Celltrion KRW 442.87B 408.53B 2025-03
Cspc Pharmaceutical CNY 4.33B 828.42M 2024-09
Divis Laboratories Ltd 13.97B 280M 2024-12
Eli Lilly USD 10.5B 624.7M 2025-03
Kangmei Pharma CNY 176.17M 370.88K 2024-09
Knight Therapeutics CAD 45.02M 2.32M 2024-09
Laboratorios Farma EUR 282.36M 172.04M 2024-12
Malin Corporation EUR 3.8M 2.6M 2020-12
Medical Developments International AUD 13.36M 2.36M 2024-06
Organigram Holdings CAD 1.05M 67.34M 2024-12
Pacira USD 134.62M 12.75M 2025-03
Perrigo USD 385.9M 18.5M 2024-12
Pharma Mar EUR 35.46M 11.59M 2025-03
Qiagen NV USD 349.8M 19.17M 2024-12
Sartorius EUR 431M 36.4M 2025-03
Sino Biopharmaceutical CNY 10.5B 3.99B 2024-12
Supernus Pharmaceuticals USD 156.96M 1.14M 2024-12
Tilray USD 61.22M 1.51M 2024-11
Zz Pientze Pharmaceu 1.39B 632.84M 2025-03



Xeris Pharmaceuticals Profitto Lordo Sulle Vendite - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - May 2025.